SEI Investments
VYNT

SEI Investments’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

SEI Investments’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-33
Closed -$4K – 3583
2018
Q2 		$4K Hold
33
– – ﹤0.01% 3232
2018
Q1 		$8K Buy
+33
New +$9.29K ﹤0.01% 2954

Other funds holding VYNT

PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
FCM
Fairbanks Capital Management Rancho Santa Fe, California $160M AUM 14.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

SEI Investments's VYNT Position: Q3 2018 in Review

SEI Investments sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q3 2018, closing a stake of 33 shares — an estimated $4K sold.

SEI Investments first reported a position in VYNT in Q1 2018 and held it in 2 quarters. The position peaked at $8K in Q1 2018. 26 funds tracked by Wall St. Rank hold VYNT as of Q3 2018.

  • SEI Investments reported no remaining Vyant Bio, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • SEI Investments sold 33 Vyant Bio, Inc. Common Stock shares in Q3 2018, an estimated $4K.
  • SEI Investments first reported a position in Vyant Bio, Inc. Common Stock in Q1 2018 and held it in 2 quarters.
  • SEI Investments's Vyant Bio, Inc. Common Stock position peaked at $8K in Q1 2018.
  • 26 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q3 2018.

Based on SEI Investments's 13F filing for Q3 2018, filed 8 Nov 2018.